Status:
RECRUITING
Evaluating the Effect of Intravenous Dexamethasone on the Duration of Spinal Anesthesia After Cesarean Delivery
Lead Sponsor:
IWK Health Centre
Conditions:
Spinal Anesthesia
Dexamethasone
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to determine the effects of intravenous (IV) dexamethasone on spinal anesthesia in healthy women having an elective Cesarean delivery (CD) at the IWK Health Centre. ...
Detailed Description
Background: Enhanced Recovery After Surgery (ERAS) is a concept that aims to achieve faster patient recovery and fewer complications after major surgery. Spinal anesthesia is a technique widely used ...
Eligibility Criteria
Inclusion Criteria:
- Non-emergent Caesarean Delivery with planned spinal anesthesia
- American Society of Anesthesia physical status class < III
- Age ≥18 years
- Term gestational age (≥37weeks)
- Singleton pregnancy
- Moderate English language fluency
Exclusion Criteria:
- Obesity (BMI ≥ 45kg/m2)
- Height < 5'0"
- Patients with significant obstetric or neonatal co-morbidities (i.e., severe maternal cardiac disease, preeclampsia, fetal anomalies)
- Opioid tolerance or sensitivity
- Intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)
- Contraindication to neuraxial analgesia (i.e., coagulopathy, infection, neuropathy)
- Abnormal spinal anatomy (i.e., severe scoliosis, spina bifida, spinal instrumentation)
- Use of chronic steroids
- A physical or psychiatric condition which impairs cooperation
Key Trial Info
Start Date :
March 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT05731960
Start Date
March 6 2023
End Date
December 1 2025
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IWK Health Centre
Halifax, Nova Scotia, Canada, B3K 6R8